HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jürgen Finke Selected Research

Melphalan (Alkeran)

1/2024In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT.
12/2023Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party.
1/2022Comparison of fludarabine-melphalan and fludarabine-treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party.
1/2021Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT).
10/2013Lowering the alemtuzumab dose in reduced intensity conditioning allogeneic hematopoietic cell transplantation is associated with a favorable early intense natural killer cell recovery.
2/2007Fatal leukoencephalopathy after reduced-intensity allogeneic stem cell transplantation.
4/2003Allogeneic stem-cell transplantation from related and unrelated donors in older patients with myeloid leukemia.
9/2002In vitro and in vivo characterization of graft-versus-tumor responses in melanoma patients after allogeneic peripheral blood stem cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jürgen Finke Research Topics

Disease

52Neoplasms (Cancer)
05/2024 - 09/2002
49Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2024 - 01/2007
44Leukemia
03/2024 - 11/2004
42Graft vs Host Disease (Graft-Versus-Host Disease)
12/2023 - 02/2003
24Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2024 - 06/2002
23Lymphoma (Lymphomas)
01/2024 - 06/2003
11Primary Myelofibrosis (Myelosclerosis)
02/2024 - 10/2016
11Multiple Myeloma
01/2024 - 02/2006
11Hematologic Neoplasms (Hematological Malignancy)
01/2023 - 09/2002
11Bronchiolitis Obliterans Syndrome
10/2022 - 03/2009
10Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2024 - 02/2007
6Infections
07/2023 - 02/2002
5B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2019 - 08/2002
4Neutropenia
07/2023 - 02/2002
4B-Cell Lymphoma (Lymphoma, B Cell)
01/2023 - 09/2003
4Residual Neoplasm
10/2020 - 06/2005
3Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2023 - 07/2007
3Pathologic Complete Response
07/2022 - 02/2012
3Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
01/2022 - 01/2017
3Cytopenia
01/2020 - 10/2016
3Chromosome Aberrations (Chromosome Abnormalities)
01/2020 - 06/2012
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2019 - 11/2006
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2019 - 08/2016
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
06/2018 - 06/2003
3Myeloid Leukemia (Leukemia, Myelocytic)
06/2012 - 04/2003
2COVID-19
01/2023 - 10/2022
2Blast Crisis (Blast Phase)
01/2023 - 10/2019
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2023 - 12/2021
2Essential Thrombocythemia
11/2020 - 01/2019
2Polycythemia Vera
11/2020 - 01/2019
2Hematologic Diseases (Blood Diseases)
10/2019 - 01/2019
2Virus Diseases (Viral Diseases)
02/2015 - 08/2005
2Refractory Anemia
10/2014 - 06/2012
2Thrombocytopenia (Thrombopenia)
07/2007 - 02/2002
2Disease Progression
08/2006 - 08/2005
1Obesity
12/2023
1Heart Diseases (Heart Disease)
10/2023
1Respiratory Tract Infections (Respiratory Tract Infection)
07/2023
1Lymphopenia (Lymphocytopenia)
07/2023
1Brain Neoplasms (Brain Tumor)
01/2023

Drug/Important Bio-Agent (IBA)

12Methotrexate (Mexate)FDA LinkGeneric
02/2019 - 04/2003
10fludarabineIBA
12/2023 - 09/2002
9Carmustine (FIVB)FDA Link
12/2023 - 09/2002
8Melphalan (Alkeran)FDA LinkGeneric
01/2024 - 09/2002
8Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
12/2023 - 08/2006
8Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2022 - 04/2003
7Thomsen-Friedenreich antibodiesIBA
01/2020 - 02/2003
7GlobulinsIBA
01/2020 - 02/2003
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2024 - 09/2015
5Cytarabine (Cytosar-U)FDA LinkGeneric
11/2017 - 08/2006
4Busulfan (Busulfex)FDA Link
10/2023 - 09/2015
4treosulfanIBA
10/2023 - 01/2020
4Proteins (Proteins, Gene)FDA Link
01/2023 - 04/2006
4Cell-Free Nucleic AcidsIBA
07/2022 - 02/2018
4Immunoglobulins (Immunoglobulin)IBA
01/2020 - 08/2005
4Tyrosine Kinase InhibitorsIBA
10/2019 - 09/2014
4Rituximab (Mabthera)FDA Link
11/2017 - 05/2016
3Inosine Triphosphate (ITP)IBA
01/2023 - 07/2007
3ruxolitinibIBA
12/2021 - 11/2018
3AntigensIBA
01/2021 - 02/2003
3Sorafenib (BAY 43-9006)FDA Link
10/2020 - 01/2018
3Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
01/2020 - 01/2016
3HLA Antigens (Human Leukocyte Antigens)IBA
03/2015 - 08/2006
3Alemtuzumab (Campath)FDA Link
10/2013 - 08/2009
2Bortezomib (Velcade)FDA Link
01/2024 - 11/2012
2daratumumabIBA
01/2023 - 01/2022
2Antiviral Agents (Antivirals)IBA
01/2023 - 02/2002
2Messenger RNA (mRNA)IBA
01/2023 - 10/2022
2Mycophenolic Acid (Cellcept)FDA LinkGeneric
08/2021 - 04/2003
2ibrutinibIBA
01/2020 - 01/2019
2SteroidsIBA
11/2018 - 08/2009
2Interleukin-15 (Interleukin 15)IBA
04/2018 - 01/2018
2Azacitidine (5 Azacytidine)FDA Link
01/2018 - 09/2012
2CytokinesIBA
06/2014 - 09/2004
2Granzymes (Granzyme)IBA
12/2013 - 09/2008
2Monoclonal AntibodiesIBA
10/2013 - 11/2012
2HLA-DQB1 antigen (HLA DQB1)IBA
11/2012 - 02/2003
2HLA-DRB1 Chains (HLA DRB1)IBA
11/2012 - 02/2003
2HLA-B Antigens (HLA-B)IBA
11/2012 - 02/2003
2HLA-A Antigens (HLA-A)IBA
11/2012 - 02/2003
2Lenalidomide (CC 5013)FDA Link
09/2012 - 02/2012
2Budesonide (Pulmicort)FDA LinkGeneric
01/2012 - 03/2009
2Interleukin-8 (Interleukin 8)IBA
10/2004 - 09/2004
1Hypoglycemic Agents (Hypoglycemics)IBA
12/2023
1Insulin (Novolin)FDA Link
12/2023
1Hemoglobins (Hemoglobin)IBA
10/2023
1Ribavirin (Virazole)FDA LinkGeneric
07/2023
1Adrenal Cortex Hormones (Corticosteroids)IBA
07/2023

Therapy/Procedure

69Stem Cell Transplantation
05/2024 - 02/2002
66Cell Transplantation
02/2024 - 05/2005
52Transplantation
05/2024 - 06/2002
44Hematopoietic Stem Cell Transplantation
03/2024 - 04/2003
25Therapeutics
01/2024 - 02/2002
13Homologous Transplantation
10/2023 - 09/2002
11Drug Therapy (Chemotherapy)
03/2024 - 03/2006
6Radiotherapy
11/2017 - 06/2003
5Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
01/2016 - 09/2002
3Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2022 - 01/2018
2Immunotherapy
11/2012 - 01/2007
2Induction Chemotherapy
09/2008 - 01/2008